Recently there is no P2X7 receptor antagonist available in the market. The P2X7 receptor is an ATP-gated, non-selective cation channel associated with many inflammatory diseases, such as epilepsy, stroke, chronic neurodegenerative, multiple sclerosis, and neuropsychiatric diseases. However, due to strict regulatory approval process, pharma companies face several challenges to introduce these drugs in the market. Each drug has to go through an approval process set by the U.S. Food & Drug Application (FDA). Leading pharma companies are investing in research and development of these drugs to lower the prevalence of various disease and conditions.
P2X7R has been reported to have pathological roles in various diseases, including autoimmune diseases (like inflammatory bowel disease and arthritis), cancer, mood disorders, chronic pain, and neurodegenerative diseases. Thus, there is an increasing demand for such drugs worldwide.
Get more Insights Analysis on this P2X7 Receptor Antagonists Market@
Key Market Drivers:
Increasing prevalence of inflammatory disorders, such as multiple sclerosis, epilepsy, stroke, chronic neurodegenerative, and neuropsychiatric diseases, worldwide is expected to aid in the growth of the P2X7 receptor antagonists market during the forecast period. For instance, according to the World Health Organization (WHO), around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally, of which 80% of people with epilepsy live in low- and middle-income countries.
Moreover, continuous research and development for the development of drugs in this category is expected to augment the growth of the P2X7 receptor antagonists market. For instance, in March 2018, Asahi Kasei Pharma and RaQualia Pharma Inc. entered into a license agreement for a novel P2X7 receptor antagonist discovered through a research collaboration between the two companies.
COVID-19 Impact Analysis:
Although the pandemic was initially manifested as a contagious respiratory infection, its other aspects quickly became apparent. P2X7 receptor antagonism could be a promising strategy to prevent or treat neurological complications in COVID-19 patients. The pandemic has created a multitude of acute challenges for healthcare industry, including supply shortages, inadequate capacity, financial loss, and the need for care redesign. However, the industry is trying to strike the optimum balance between the pandemic and essential health services, worldwide. This in turn is expected to boost the growth of the market.
Major Players in P2X7 Receptor Antagonists Market
GlaxoSmithKline Plc, Johnson & Johnson, AstraZeneca Plc, RaQualia Pharma, Evotec AG, and Asahi Kasei Corporation.
Get PDF Brochure with Latest Insights @
The P2X7 receptor antagonists market is expected to exhibit a CAGR of XX % during the forecast period due to the increased focus towards the introduction of novel P2X7 receptor antagonist. For instance, in January 2021, Eli Lilly and Company and Asahi Kasei Pharma announced a license agreement whereby Lilly will acquire the exclusive rights for AK1780 from Asahi Kasei Pharma. AK1780 is a P2X7 receptor antagonist in early-stage clinical development for neuro-inflammatory pain conditions
Among regions, North America is expected to witness robust growth in the P2X7 receptor antagonists market, owing to the increasing prevalence of inflammatory disorders in this region. For instance, according to the Centers for Disease Control and Prevention (CDC), someone in the United States has a stroke every 40 seconds. Every year, more than 795,000 Americans have a stroke.
Reasons to Purchase this Report
• Current and future of global P2X7 Receptor Antagonists market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Critical Questions Answered in the Report
What are ongoing trends that will shape market growth curve for global P2X7 Receptor Antagonists market?
What are the drivers and challenges affecting the P2X7 Receptor Antagonists market demand?
What are the recent technological advancement in the P2X7 Receptor Antagonists market?
What are key trends and opportunities that will prevail the revenue growth of P2X7 Receptor Antagonists market players?
How will evolving regulatory policies impact the market growth?
Why Coherent Market Insights?
• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the P2X7 Receptor Antagonists market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years
• Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
Inquire more about this report @
Our analysts are experts in this field with years of experience. We at Coherent Market Insights maintain the highest level of accuracy and transparency in the report. The primary and secondary resources used in the report are taken from reliable and high authority sources to deliver 100% accurate and trusted data.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027